Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,453 | -11,487 | -44,170 | -32,770 | -21,645 |
| Depreciation Amortization | -908 | -441 | -75 | N/A | N/A |
| Accounts payable and accrued liabilities | -693 | -953 | 958 | 497 | 560 |
| Other Working Capital | -2,510 | -963 | -69 | -705 | 2,145 |
| Other Operating Activity | 4,332 | 2,875 | 6,652 | 5,276 | 3,204 |
| Operating Cash Flow | $-20,232 | $-10,969 | $-36,704 | $-27,702 | $-15,736 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,196 | -16,048 | -26,498 | N/A | N/A |
| Investing Cash Flow | $-2,196 | $-16,048 | $-26,498 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,224 | 1,224 | 9,582 | 7,568 | 3,871 |
| Common Stock Repurchased | -106 | -105 | -3 | -3 | N/A |
| Financing Cash Flow | $1,118 | $1,119 | $9,579 | $7,565 | $3,871 |
| Beginning Cash Position | 37,142 | 37,142 | 90,765 | 90,765 | 90,765 |
| End Cash Position | 15,832 | 11,244 | 37,142 | 70,628 | 78,900 |
| Net Cash Flow | $-21,310 | $-25,898 | $-53,623 | $-20,137 | $-11,865 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,232 | -10,969 | -36,704 | -27,702 | -15,736 |
| Free Cash Flow | -20,232 | -10,969 | -36,704 | -27,702 | -15,736 |